Related Experiment Video
Updated: Apr 25, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
The role of Epstein-Barr virus in multiple sclerosis: From pathogenesis to therapeutic potential
G Bellucci1, R Mechelli2, R Bigi3
1Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, 00189 Rome, Italy; Department of Neurology, University of California, San Francisco, CA, United States.
Abstract:
A growing body of evidence positions Epstein-Barr virus (EBV) as a central agent in the etiopathogenesis of multiple sclerosis (MS). Compelling epidemiological studies now demonstrate that EBV infection precedes MS onset and is a necessary precondition for disease development. This is supported by pathology findings revealing EBV-infected B cells within CNS lesions and immunogenetic data linking viral and human genetic susceptibility to MS risk. Mechanistically, EBV appears to act as an upstream trigger that reshapes B cell function, promotes molecular mimicry with CNS antigens, and drives compartmentalized neuroinflammation. In this Review, we synthesize epidemiological, pathological, immunogenetic, and clinical-therapeutic evidence to construct a coherent model of EBV-driven MS pathogenesis. We examine how current MS therapies intersect with EBV biology and discuss the challenges and opportunities in developing EBV-targeted strategies, including vaccines and antivirals, for disease prevention and early intervention. Finally, we highlight key unresolved questions and outline a translational research agenda aimed at intercepting MS through virologically informed approaches.
Insights
Epstein-Barr virus (EBV) infection is a necessary precursor to multiple sclerosis (MS) development. This review synthesizes evidence to model EBV
Area of Science:
- Neuroimmunology
- Virology
- Epidemiology
Background:
- Multiple sclerosis (MS) is a chronic neurological disease with complex etiology.
- Epstein-Barr virus (EBV) infection is increasingly implicated in MS pathogenesis.
- The link between EBV and MS requires further elucidation.
Purpose of the Study:
- To synthesize current evidence on the role of EBV in multiple sclerosis.
- To construct a model of EBV-driven MS pathogenesis.
- To explore therapeutic strategies targeting EBV for MS prevention and treatment.
Main Methods:
- Review of epidemiological, pathological, and immunogenetic studies.
- Analysis of clinical-therapeutic data.
- Synthesis of evidence to propose a pathogenetic model.
Main Results:
- EBV infection precedes MS onset and is a necessary precondition.
- EBV-infected B cells are found in CNS lesions.
- EBV reshapes B cell function, promotes molecular mimicry, and drives neuroinflammation.
Conclusions:
- EBV is a central factor in MS pathogenesis.
- Current MS therapies have varying interactions with EBV biology.
- EBV-targeted strategies, including vaccines and antivirals, offer potential for MS prevention and early intervention.
More Related Videos
Related Concept Videos
Multiple Sclerosis l: Introduction
Inhibitors of Viral Protein Synthesis
Microorganisms in Medicine and Therapeutics
Encephalitis ll: Pathophysiology

